CN1231484C - 苯并[b]吡喃并[3,2－h]吖啶－7－酮化合物、它们的制备方法和含有它们的药物组合物 - Google Patents

苯并[b]吡喃并[3,2－h]吖啶－7－酮化合物、它们的制备方法和含有它们的药物组合物 Download PDF

Info

Publication number
CN1231484C
CN1231484C CNB021253153A CN02125315A CN1231484C CN 1231484 C CN1231484 C CN 1231484C CN B021253153 A CNB021253153 A CN B021253153A CN 02125315 A CN02125315 A CN 02125315A CN 1231484 C CN1231484 C CN 1231484C
Authority
CN
China
Prior art keywords
branched
formula
compound
straight
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021253153A
Other languages
English (en)
Chinese (zh)
Other versions
CN1398863A (zh
Inventor
M·科克
F·蒂勒奎
S·米歇尔
E·塞甘
A·奥马里
J·希克曼
A·皮埃尔
B·普法伊费尔
P·勒纳尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Publication of CN1398863A publication Critical patent/CN1398863A/zh
Application granted granted Critical
Publication of CN1231484C publication Critical patent/CN1231484C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CNB021253153A 2001-07-25 2002-07-24 苯并[b]吡喃并[3,2－h]吖啶－7－酮化合物、它们的制备方法和含有它们的药物组合物 Expired - Fee Related CN1231484C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0109910 2001-07-25
FR0109910A FR2827864B1 (fr) 2001-07-25 2001-07-25 Nouveaux derives de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
CN1398863A CN1398863A (zh) 2003-02-26
CN1231484C true CN1231484C (zh) 2005-12-14

Family

ID=8865868

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021253153A Expired - Fee Related CN1231484C (zh) 2001-07-25 2002-07-24 苯并[b]吡喃并[3,2－h]吖啶－7－酮化合物、它们的制备方法和含有它们的药物组合物

Country Status (24)

Country Link
US (1) US6642248B2 (https=)
EP (1) EP1297835B1 (https=)
JP (1) JP2003055381A (https=)
KR (1) KR100498868B1 (https=)
CN (1) CN1231484C (https=)
AR (1) AR036346A1 (https=)
AT (1) ATE373478T1 (https=)
AU (1) AU2002300268B2 (https=)
BR (1) BR0202864A (https=)
CA (1) CA2395652C (https=)
DE (1) DE60222515T2 (https=)
DK (1) DK1297835T3 (https=)
EA (1) EA005374B1 (https=)
ES (1) ES2294090T3 (https=)
FR (1) FR2827864B1 (https=)
HK (1) HK1053646B (https=)
HU (1) HUP0202485A3 (https=)
MX (1) MXPA02006914A (https=)
NO (1) NO20023556L (https=)
NZ (1) NZ520377A (https=)
PL (1) PL355188A1 (https=)
PT (1) PT1297835E (https=)
SI (1) SI1297835T1 (https=)
ZA (1) ZA200205961B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2856687B1 (fr) * 2003-06-25 2005-09-16 Servier Lab Nouveaux derives de benzo[a]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865734B1 (fr) * 2004-02-03 2006-05-19 Servier Lab NOUVAEUX DERIVES DE BENZO[b]CHROMENO-NAPHTHYRIDIN-7-ONE ET DE PYRANO[2'3':7,8]QUINO[2,3-b]QUINOXALIN-7-ONE, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
FR2879600B1 (fr) * 2004-12-22 2007-02-09 Servier Lab Nouveaux derives cinnamates de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN107068881B (zh) * 2016-04-25 2019-12-03 中节能万润股份有限公司 一种含有吖啶酮类化合物的有机电致发光器件及其应用
CN115594592B (zh) * 2021-06-28 2024-03-19 江西天宇化工有限公司 一种2-氯-3-硝基苯甲酸的制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224169D0 (en) * 1992-11-18 1993-01-06 Lilly Industries Ltd Pharmaceutical compounds
HRP960352A2 (en) * 1996-07-26 1998-08-31 Pliva Pharm & Chem Works Novel coumarin quinoline carboxylic acids
FR2772765B1 (fr) * 1997-12-19 2000-03-17 Adir Nouveaux derives de l'acronycine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2795071B1 (fr) * 1999-06-16 2001-07-27 Adir Nouveaux derives de carboxylate de 7-oxo-2,3,7,14- tetrahydro-1h-benzo[b]pyrano[3,2,h] acridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
PT1297835E (pt) 2007-10-19
DK1297835T3 (da) 2008-01-28
CN1398863A (zh) 2003-02-26
PL355188A1 (en) 2003-01-27
EA200200712A1 (ru) 2003-02-27
BR0202864A (pt) 2003-06-03
EP1297835B1 (fr) 2007-09-19
FR2827864B1 (fr) 2005-09-16
HK1053646B (zh) 2006-04-21
CA2395652C (fr) 2008-12-30
DE60222515D1 (de) 2007-10-31
FR2827864A1 (fr) 2003-01-31
DE60222515T2 (de) 2008-07-03
HK1053646A1 (en) 2003-10-31
NO20023556L (no) 2003-01-27
ES2294090T3 (es) 2008-04-01
HUP0202485A2 (hu) 2003-04-28
HUP0202485A3 (en) 2005-07-28
SI1297835T1 (sl) 2007-12-31
CA2395652A1 (fr) 2003-01-25
HU0202485D0 (https=) 2002-09-28
AR036346A1 (es) 2004-09-01
ZA200205961B (en) 2003-04-01
EP1297835A1 (fr) 2003-04-02
US6642248B2 (en) 2003-11-04
AU2002300268B2 (en) 2008-05-22
JP2003055381A (ja) 2003-02-26
MXPA02006914A (es) 2005-07-25
KR20030010513A (ko) 2003-02-05
NO20023556D0 (no) 2002-07-25
US20030073841A1 (en) 2003-04-17
NZ520377A (en) 2004-03-26
EA005374B1 (ru) 2005-02-24
KR100498868B1 (ko) 2005-07-04
ATE373478T1 (de) 2007-10-15

Similar Documents

Publication Publication Date Title
CN1036918C (zh) 苯并吡喃衍生物及含有此衍生物的k+通道活化剂
CN1077575C (zh) 喜树碱衍生物及其制备方法和用途及其中间体
CN1049500A (zh) 苯并吡喃化合物，其生产方法及药物组合物
CN1275966C (zh) 吡啶并吡啶并吡咯并 [ 3 , 2 － g ]吡咯并 [ 3 , 4 － e ]吲哚和吡啶并吡咯并[ 2 , 3 － a ]吡咯并 [ 3 , 4 －c ]咔唑化合物 ,其制备方法以及其药物组合物
CN1305482A (zh) 青蒿素衍生物,其制备方法以及含有它们的药物组合物
CN1280276C (zh) 9－氨基吖啶衍生物及其制备方法
CN1152040C (zh) 新颖的咔唑衍生物,其制备方法和含有它们的药物组合物
CN1155601C (zh) 二氧杂环戊二烯-6(5aH)-酮化合物、其制备方法及其药物组合物
CN1231484C (zh) 苯并[b]吡喃并[3,2－h]吖啶－7－酮化合物、它们的制备方法和含有它们的药物组合物
CN1147491C (zh) 新的吖啶羧酸酯化合物、其制备方法及其药物组合物
CN1313462C (zh) 3－(4－氧代－4h－苯并吡喃－2－基)－(1h)－喹啉－4－酮衍生物、其制备方法和含有它们的药物组合物
CN1297556C (zh) 苯并[b]色烯并－萘啶－7－酮和吡喃并[2＇,3＇:7,8]喹啉并[2,3－b]喹喔啉－7－酮化合物、其制备方法及药用组合物
CN1289502C (zh) 苯并[a]吡喃并[3，2－h]吖啶－7－酮化合物、其制备方法及其药物组合物
CN1086188C (zh) 新颖的菲啶鎓衍生物
CN1101818C (zh) 20(s)－喜树碱的水溶性C－环类似物,制备方法和用途
CN1284781C (zh) 具有抗肿瘤活性的多环化合物
CN1796363A (zh) 苯丙烯酸苯丙烯酯和苯丙酸苯丙酯类化合物及其制备方法和用途
CN100338071C (zh) 取代的苯并[e][1,4]嗪并[3,2－g]异吲哚衍生物、制备它们的方法和包含它们的药物组合物
CN1796387A (zh) 苯并[b]吡喃并[3,2－h]吖啶－7－酮肉桂酸酯化合物、其制备方法和其药物组合物
HK1032783B (en) New compounds of 7-oxo-2,3,7,14-tetrahydro-1 h-benzo(b)pyrano(3,2-h)acridin carboxylate, a process for their preparation and pharmaceutical compositions containing them
HK1081192B (en) Benzo[b]chromeno-naphthyridin-7-one and pyrano[2',3':7,8]quino[2,3-b]quinoxalin-7-one compounds, process for their preparation and pharmaceutical compositions containing them
HK1088328A (en) Benzo[b]pyrano[3,2-h]acridin-7-one cinnamate compounds, a process for their preparation and pharmaceutical compositions containing them
HK1070360B (en) Benzo[a]pyrano[3,2-h]acridin-7-one compounds, a process for their preparation and pharmaceutical compositions thereof
HK1084112B (en) Substituted benzol[e][1,4] oxazino[3,2-g] isoindole derivatives, method for preparing same and pharmaceutical compositions containing same
HK1081191B (en) 3-(4-oxo-4h-chromen-2-yl)-(1h)-quinoline-4-one derivatives, method for preparing same and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CI01 Publication of corrected invention patent application

Correction item: Inventor

Correct: A. Pierre|B Pfeiffer

False: Less 7,8 inventor

Number: 9

Volume: 19

CI02 Correction of invention patent application

Correction item: Inventor

Correct: A. Pierre|B Pfeiffer

False: Less 7,8 inventor

Number: 9

Page: The title page

Volume: 19

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: MISSING THE 7TH, 8 INVENTOR TO: A. PIEL B. PFEIFFER

ERR Gazette correction

Free format text: CORRECT: INVENTOR; FROM: MISSING THE 7TH, 8 INVENTOR TO: A. PIEL B. PFEIFFER

C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee